Sentry LLC’s Eli Lilly LLY Stock Holding History

Sentry LLC’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.61M	Hold	5,012	–	–	1.47%	13
2025 Q4	$5.39M	Hold	5,012	–	–	1.47%	11
2025 Q3	$3.82M	Buy	5,012 +7	+0.1%	+$5.21K	0.95%	17
2025 Q2	$3.9M	Hold	5,005	–	–	0.78%	17
2025 Q1	$4.13M	Buy	5,005 +1	+0%	+$832	0.8%	15
2024 Q4	$3.86M	Sell	5,004 -1	-0%	-$828	0.75%	15
2024 Q3	$4.43M	Buy	5,005 +1	+0%	+$899	0.85%	15
2024 Q2	$4.53M	Sell	5,004 -1	-0%	-$800	0.83%	14
2024 Q1	$3.89M	Sell	5,005 -2	-0%	-$1.42K	0.73%	15
2023 Q4	$2.92M	Buy	5,007 +2	+0%	+$1.17K	0.62%	17
2023 Q3	$2.69M	Hold	5,005	–	–	0.57%	18
2023 Q2	$2.35M	Hold	5,005	–	–	0.51%	18
2023 Q1	$1.72M	Buy	+5,005	New	+$1.69M	0.4%	19

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sentry LLC's LLY Position: Q1 2026 in Review

Sentry LLC held its Eli Lilly (LLY) position steady in Q1 2026 at 5,012 shares worth $4.61M. The position accounts for 1.47% of the portfolio, ranked #13.

Sentry LLC first reported a position in LLY in Q1 2023 and has held it in 13 quarters since. The position peaked at $5.39M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Sentry LLC held 5,012 shares of Eli Lilly worth $4.61M as of Q1 2026.
Sentry LLC left its Eli Lilly share count unchanged in Q1 2026.
Eli Lilly made up 1.47% of Sentry LLC's portfolio in Q1 2026, its #13 holding.
Sentry LLC first reported a position in Eli Lilly in Q1 2023 and has held it in 13 quarters since.
Sentry LLC's Eli Lilly position peaked at $5.39M in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Sentry LLC's 13F filing for Q1 2026, filed 23 Apr 2026.